Stichting Health Action International

Tweet this page
<
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 14 Apr 2020
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

450,000€

Financial year: Jan 2019 - Dec 2019

Lobbyists (Full time equivalent)

3.75 Fte (6)

Lobbyists with EP accreditation

2

High-level Commission meetings

5

Lobbying Costs over the years

  • Info

    Stichting Health Action International   (HAI)

    EU Transparency Register

    44361352681-84 First registered on 30 Nov 2009

    Goals / Remit

    Health Action International is a non-profit, independent global network of consumer groups, public interest NGOs, healthcare professionals, academics, and individuals working and interested on pharmaceutical policy issues. HAI’s mission is to increase access to essential medicines and improve their rational use through research excellence and evidence-based advocacy.

    In Europe, HAI has grown to become a pre-eminent voice in medicines policy intervention/discussion, supported by a strong European network of approximately 118 individual and organisation members from 20 European Union (EU) Member States and other non-EU countries. The HAI Europe projects team, based in Amsterdam, is responsible for coordinating the work programme and related activities within the European region. HAI monitors and advocates on EU policies that affect medicines on three key thematic priorities: Access to Needed Medicines, the Rational Use of Medicines, and the Democratisation of Medicines Policy. HAI’s work is carried out in collaboration with various stakeholders, including public health orientated NGOs, academia and other stakeholders. Targeted campaigns and activities are implemented to ensure that public awareness is raised with the aim to sensitise decision-makers in governments, EU institutions and general public to support policies that improve public health.

    Main EU files targeted

    HAI advocates for policy initiatives that help to address current shortfalls/shortcomings on access to medicines. In Europe, HAI monitors EU initiatives with an impact on access to medicines, their rational use and on the democratisation of medicines policy. Where needed, we issue recommendations for improvement on specific topics. EU legislation, policies and initiatives of particular interest include: proposals EU cooperation on Health Technology Assessment; EUnetHTA; review of EU Orphan Regulation and orphan designation and other IP incentives; EU IP law and enforcement strategy; Supplementary Protection Certificate Regulation (manufacturing waiver and more) ; Competition policy; Euripid and other price sharing projects; EU trade agreements with impact on access to medicines; Horizon 2020’ Innovative Medicines Initiative and Horizon Europe; Multiannual Financial Framework (MFF); implementation One Health Action Plan against AMR; Clinical Trial Regulation; EMA's policies and activities; tackling medicines shortages; HAI also advocates for stricter regulations on pharmaceutical promotion in Europe specially among healthcare professionals and students.

    Address

    Head Office
    Overtoom, 60/II
    Amsterdam 1054HK
    NETHERLANDS
  • People

    Total lobbyists declared

    6

    Employment timeLobbyists
    100%2
    75%1
    50%1
    25%2

    Lobbyists (Full time equivalent)

    3.75

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    2 accreditations were / are live (in bold) for the selected state of 14 Apr 2020

    Name Start date End Date
    Ms Hannah VAN KOLFSCHOOTEN 14 Dec 2022 14 Dec 2023
    Ms Janneke VAN OIRSCHOT 09 Dec 2022 09 Dec 2023
    Mr Jaume VIDAL 04 Nov 2022 04 Nov 2023
    Ms Ellie WHITE 27 Oct 2021 11 Feb 2022
    Mr Jaume VIDAL 27 Oct 2021 27 Oct 2022
    Mr Jaume VIDAL 19 Sep 2019 19 Sep 2020
    Ms Ellie WHITE 14 Sep 2019 12 Sep 2020
    Ms Ancel·la Santos Quintano 13 Oct 2018 25 Apr 2019
    Mr Jaume VIDAL 13 Oct 2018 19 Sep 2019
    Ms Ancel·la Santos Quintano 14 Oct 2017 13 Oct 2018
    Mr Jaume VIDAL 20 Jul 2017 07 Jul 2018
    Ms Tessel Mellema 07 Sep 2016 21 Jul 2017
    Ms Ancel·la Santos Quintano 07 Sep 2016 07 Sep 2017
    Ms Tessel Mellema 27 Aug 2015 26 Aug 2016
    Ms Ancel·la Santos Quintano 27 Aug 2015 26 Aug 2016
    Ms Aliénor Devalière 27 Aug 2015 23 Jun 2016
    Ms Ancel·la Santos Quintano 01 May 2014 05 Jun 2015
    Ms Aliénor Devalière 07 Jun 2014 05 Jun 2015
    Mrs Aliénor Devalière 07 Jun 2014 27 Jan 2015
    Ms Tessel Mellema 01 May 2014 05 Jun 2015
    Mrs Ancel·la Santos Quintano 01 May 2014 27 Jan 2015
    Ms Tessel Mellema 25 Jun 2013 01 May 2014
    Mrs Ancel·la Santos Quintano 30 May 2013 01 May 2014
    Ms Katrina Perehudoff 22 Sep 2012 17 Jun 2013
    Ms Tessel Mellema 20 Sep 2012 25 Jun 2013

    Complementary Information

    HAI has two full-time policy advisors that are solely focused on our EU projects. They are supported by Admin, Communications, PME & our Executive Director.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    III - Non-governmental organisations

    Subcategory

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    HAI is a member of the European Public Health Alliance (EPHA), the International Society of Drug Bulletins (ISDB), the Transatlantic Consumer Dialogue (TACD), the Medicines in Europe Forum (MiEF), the European Alliance for Responsible R&D and Affordable Medicines, the Antimicrobial Resistance Coalition, Health Systems Advocacy partnership, Global Snakebite Initiative, Medicines Transparency Alliance (MeTA). In addition, HAI enters into strategic partnership with other associations when collaborating on certain topics thus tapping into extended expertise as required.

    HAI is also a member of the EMA’s Patients and Consumers Working Party (PCWP) and the HTA Network Stakeholder Pool.

    HAI is in official relations with the WHO and collaborates with the organisation on several projects as well as attending governing bodies and ad-hoc meetings.

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2019 - Dec 2019

    Lobbying costs for closed financial year

    450,000€

    EU grant income for closed financial year

    236,335 € (Source: CHAFEA)

    Other financial info

    All our funding sources have been described in section B.

    HAI’s accounting and financial reporting is subject to an annual independent audit, the outcomes of which are reported to the Foundation Board and published on HAI’s website (see http://haiweb.org/governance/policies-plans-reports/ )

    HAI maintains a strict independence policy to avoid conflicts of interest.

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    None

    Communication activities

    For our publications please visit: http://haiweb.org/publications-page/
    For our press releases and other news please visit: https://haiweb.org/news/
    In 2020 HAI brought to a close its four-year campaign on transparency in the Netherlands, Our Medicines Our Right. The campaign aimed to raise public awareness in The Netherlands and urge Dutch politicians to take action and increase transparency of price and R&D costs of medicines. You can find out more about the campaign here: www.ourmedicinesourright.eu, and about our closing stunt here: https://haiweb.org/pharmaceutical-companies-secrecy/.Other examples of our policy implementation and communications work are our work with the London School of Economics on the risk of bias in clinical trials for cancer drugs (https://haiweb.org/cancer-drug/) and our advocacy work in the European Parliament (https://haiweb.org/what-we-do/hais-work-with-the-epwg-on-access-to-medicines-and-poverty-related-diseases/).

    Other activities

    HAI is a member of the European Medicines Agency Patients' and Consumers' Working Party (PCWP); and a member of the HTA Network Stakeholder Pool.

  • Meetings

    Meetings

    5 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

Download this datacard